Literature DB >> 11306596

More weapons in the arsenal against ischemic retinopathy.

E Keshet1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11306596      PMCID： PMC199562          DOI： 10.1172/JCI12704

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

1.  Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.

Authors:  A Das; A McLamore; W Song; P G McGuire
Journal:  Arch Ophthalmol       Date:  1999-04

2.  Reciprocal relation between VEGF and NO in the regulation of endothelial integrity.

Authors:  Y Tsurumi; T Murohara; K Krasinski; D Chen; B Witzenbichler; M Kearney; T Couffinhal; J M Isner
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.

Authors:  M S Seo; N Kwak; H Ozaki; H Yamada; N Okamoto; E Yamada; D Fabbro; F Hofmann; J M Wood; P A Campochiaro
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

Authors:  M Ziche; L Morbidelli; R Choudhuri; H T Zhang; S Donnini; H J Granger; R Bicknell
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP.

Authors:  N Ghiso; R M Rohan; S Amano; R Garland; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

6.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

Authors:  A Papapetropoulos; G García-Cardeña; J A Madri; W C Sessa
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

7.  VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells.

Authors:  J D Hood; C J Meininger; M Ziche; H J Granger
Journal:  Am J Physiol       Date:  1998-03

8.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.

Authors:  G S Robinson; E A Pierce; S L Rook; E Foley; R Webb; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.

Authors:  J Stone; T Chan-Ling; J Pe'er; A Itin; H Gnessin; E Keshet
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-02       Impact factor: 4.799

10.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.

Authors:  T Alon; I Hemo; A Itin; J Pe'er; J Stone; E Keshet
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440
View more
  2 in total

1.  Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche.

Authors:  Zhiping Liu; Jiean Xu; Qian Ma; Xiaoyu Zhang; Qiuhua Yang; Lina Wang; Yapeng Cao; Zhimin Xu; Amany Tawfik; Ye Sun; Neal L Weintraub; David J Fulton; Mei Hong; Zheng Dong; Lois E H Smith; Ruth B Caldwell; Akrit Sodhi; Yuqing Huo
Journal:  Sci Transl Med       Date:  2020-08-05       Impact factor: 17.956

2.  Differential Effects of Cytopathic Hypoxia on Human Retinal Endothelial Cellular Behavior: Implication for Ischemic Retinopathies.

Authors:  Shaimaa El-Tanani; Thangal Yumnamcha; Lalit Pukhrambam Singh; Ahmed S Ibrahim
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.